Houston, TX — November 25, 2025 — Leads & Copy — Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, will participate in two upcoming healthcare conferences.
Dr. Arun Swaminathan, Ph.D., Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 2, 2025, from 8:45-9:05 am ET in Miami, FL. Interested parties can access the live webcast at https://wsw.com/webcast/evercore52/coya/2359192. The company’s management team will also be available for one-on-one meetings during the conference.
Additionally, Dr. Fred Grossman, D.O., FAPA, President and Chief Medical Officer, will participate in a roundtable discussion titled “Charting the Path Forward for Combination Therapy in Alzheimer’s Disease: Challenges, Considerations, and Collaborative Solutions” at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference on December 2, 2025, from 3:10-3:50 pm ET in San Diego, CA. Further details about the panel can be found at https://www.ctad-alzheimer.com/program.
Both the live and archived webcasts will be available on Coya Therapeutics’ website in the Investor Relations section under Events and Presentations. The webcast replay will be accessible for 90 days.
Coya Therapeutics, Inc., headquartered in Houston, TX, is focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders. The company’s investigational product candidate pipeline leverages multiple therapeutic modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs, including Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
Dysfunctional Tregs underlie numerous conditions, including neurodegenerative, metabolic, and autoimmune diseases and may lead to sustained inflammation and oxidative stress resulting in a lack of homeostasis of the immune system. Coya is developing proprietary treatments that target systemic inflammation and neuroinflammation.
For more information about Coya Therapeutics, please visit www.coyatherapeutics.com.
Contacts:
No contact person was named.
Source: Coya Therapeutics, Inc.
